Drawing for BIOSYNTEX

USPTO serial 97422601

BIOSYNTEX

Reviewed by CopyMark Law Group

Status 602
Filing date
Status date
Registration date
Examiner
GILBERT, HANNAH B

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIOSYNTEX?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

Owner

  • BioSyntex Laboratories, LLC

    Oro Valley, AZ, US

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for medical and scientific research use; pharmaceutical preparations for scientific research; investigational pharmaceutical preparations for clinical and preclinical research use; synthetic peptides for medical use; biological compounds for pharmaceutical research use; drug delivery agents for delivery of pharmaceutical preparations; drug delivery agents in the nature of nanoparticles, liposomes or vesicles for pharmaceutical use; injectable pharmaceutical preparations for research use; transdermal pharmaceutical preparations for research use; implantable pharmaceutical preparations for research use; controlled-release pharmaceutical preparations for research use; pharmaceutical preparations for use in drug discovery and development; pharmaceutical preparations for use in translational medical research; all of the foregoing excluding dietary supplements, nutraceuticals, vitamins, mineral supplements, probiotic preparations, and consumer wellness products.ACTIVEAug 4, 2022

Prosecution history

DateCodeEvent
Aug 10, 2026MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 10, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 24, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 24, 2026GNRTNON-FINAL ACTION E-MAILED
Apr 24, 2026CNRTNON-FINAL ACTION WRITTEN
Jan 30, 2026AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jan 30, 2026PARITEAS VOLUNTARY AMENDMENT RECEIVED
Jan 12, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jan 12, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 9, 2026ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 29, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sep 16, 2025DOCKASSIGNED TO EXAMINER
Apr 25, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 24, 2024GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 24, 2024GNSLLETTER OF SUSPENSION E-MAILED
Oct 24, 2024CNSLSUSPENSION LETTER WRITTEN
Aug 29, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 29, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 29, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 29, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 29, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 29, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVED
May 29, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 29, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 29, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 29, 2024GNRTNON-FINAL ACTION E-MAILED
Feb 29, 2024CNRTNON-FINAL ACTION WRITTEN
Feb 6, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 6, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 6, 2024ALIEASSIGNED TO LIE
Sep 14, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 14, 2023NREVNOTICE OF REVIVAL - E-MAILED
Sep 14, 2023NREVNOTICE OF REVIVAL - E-MAILED
Sep 14, 2023PETGPETITION TO REVIVE-GRANTED
Sep 14, 2023PROATEAS PETITION TO REVIVE RECEIVED
Jul 13, 2023MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 12, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jul 12, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 8, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 8, 2023GNRTNON-FINAL ACTION E-MAILED
Mar 8, 2023CNRTNON-FINAL ACTION WRITTEN
Feb 23, 2023DOCKASSIGNED TO EXAMINER
May 26, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 25, 2022NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance